Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 1
1974 1
1975 2
1976 2
1977 3
1978 1
1979 3
1980 5
1981 10
1982 2
1983 13
1984 17
1985 15
1986 18
1987 20
1988 26
1989 31
1990 41
1991 32
1992 48
1993 50
1994 62
1995 69
1996 69
1997 90
1998 65
1999 69
2000 91
2001 101
2002 113
2003 145
2004 135
2005 129
2006 123
2007 140
2008 157
2009 143
2010 157
2011 162
2012 189
2013 203
2014 212
2015 260
2016 252
2017 285
2018 265
2019 268
2020 292
2021 338
2022 289
2023 291
2024 120

Text availability

Article attribute

Article type

Publication date

Search Results

4,901 results

Results by year

Filters applied: . Clear all
Page 1
Graft-versus-host disease.
Moreno DF, Cid J. Moreno DF, et al. Med Clin (Barc). 2019 Jan 4;152(1):22-28. doi: 10.1016/j.medcli.2018.07.012. Epub 2018 Oct 9. Med Clin (Barc). 2019. PMID: 30309668 Review. English, Spanish.
Graft-versus-host disease (GVHD) is the most frequent and potentially fatal complication of an allogeneic hematopoietic progenitor cell transplantation. ...
Graft-versus-host disease (GVHD) is the most frequent and potentially fatal complication of an allogeneic hemato …
Review of Graft-Versus-Host Disease.
Ramachandran V, Kolli SS, Strowd LC. Ramachandran V, et al. Dermatol Clin. 2019 Oct;37(4):569-582. doi: 10.1016/j.det.2019.05.014. Epub 2019 Jul 10. Dermatol Clin. 2019. PMID: 31466596 Review.
Graft-versus-host disease (GVHD) is an adverse immunologic phenomenon following allogenic hematopoietic stem cell transplant. ...
Graft-versus-host disease (GVHD) is an adverse immunologic phenomenon following allogenic hematopoietic stem cel …
Acute Graft-Versus-Host Disease: A Brief Review.
Aladağ E, Kelkitli E, Göker H. Aladağ E, et al. Turk J Haematol. 2020 Feb 20;37(1):1-4. doi: 10.4274/tjh.galenos.2019.2019.0157. Epub 2019 Sep 2. Turk J Haematol. 2020. PMID: 31475512 Free PMC article. Review.
Graft-versus-host disease (GvHD) is an important complication that can be observed after allogeneic hematopoietic stem cell transplantation (allo-HSCT). ...
Graft-versus-host disease (GvHD) is an important complication that can be observed after allogeneic hematopoieti …
Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.
Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Baumrin E, et al. J Am Acad Dermatol. 2024 Jan;90(1):1-16. doi: 10.1016/j.jaad.2022.12.024. Epub 2022 Dec 23. J Am Acad Dermatol. 2024. PMID: 36572065 Review.
Chronic graft-versus-host disease is a major complication of allogeneic hematopoietic cell transplantation and a leading cause of long-term morbidity, nonrelapse mortality, and impaired health-related quality of life. ...Part I reviews the epidemiology …
Chronic graft-versus-host disease is a major complication of allogeneic hematopoietic cell transplantation and a …
Acute graft-versus-host disease.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2023 Jun 8;9(1):28. doi: 10.1038/s41572-023-00444-3. Nat Rev Dis Primers. 2023. PMID: 37291261 No abstract available.
Vulvovaginal Graft-Versus-Host Disease.
Kornik RI, Rustagi AS. Kornik RI, et al. Obstet Gynecol Clin North Am. 2017 Sep;44(3):475-492. doi: 10.1016/j.ogc.2017.05.007. Obstet Gynecol Clin North Am. 2017. PMID: 28778644 Review.
Vulvovaginal chronic graft-versus-host disease (cGVHD) is an underrecognized complication of stem cell transplantation. ...
Vulvovaginal chronic graft-versus-host disease (cGVHD) is an underrecognized complication of stem cell transplan …
Oral graft-versus-host disease.
Kuten-Shorrer M, Woo SB, Treister NS. Kuten-Shorrer M, et al. Dent Clin North Am. 2014 Apr;58(2):351-68. doi: 10.1016/j.cden.2013.12.007. Dent Clin North Am. 2014. PMID: 24655527 Review.
Allogeneic hematopoietic cell transplantation (allo-HCT) is used for the treatment of a variety of disorders, primarily hematologic malignancies. Graft-versus-host disease (GVHD) is a significant complication following allo-HCT and a major cause of mor …
Allogeneic hematopoietic cell transplantation (allo-HCT) is used for the treatment of a variety of disorders, primarily hematologic malignan …
Belumosudil for chronic graft-versus-host disease.
Taylor B, Cohen J, Tejeda J, Wang TP. Taylor B, et al. Drugs Today (Barc). 2022 May;58(5):203-212. doi: 10.1358/dot.2022.58.5.3400705. Drugs Today (Barc). 2022. PMID: 35535812 Review.
Chronic graft-versus-host disease (cGvHD) is a multisystem disease that is diagnosed in up to 70% of patients following allogeneic hematopoietic cell transplantation. ...
Chronic graft-versus-host disease (cGvHD) is a multisystem disease that is diagnosed in up to 70% of patients fo …
Update on ocular graft-versus-host disease.
Nair S, Vanathi M, Mukhija R, Tandon R, Jain S, Ogawa Y. Nair S, et al. Indian J Ophthalmol. 2021 May;69(5):1038-1050. doi: 10.4103/ijo.IJO_2016_20. Indian J Ophthalmol. 2021. PMID: 33913829 Free PMC article. Review.
Ocular graft-versus-host disease (oGVHD) occurs as a complication following hematopoietic stem cell transplantation and is associated with significant ocular morbidity resulting in a marked reduction in the quality of life. ...
Ocular graft-versus-host disease (oGVHD) occurs as a complication following hematopoietic stem cell transplantat …
Graft-versus-host disease management.
Mistrik M, Bojtarova E, Sopko L, Masakova L, Roziakova L, Martinka J, Batorova A. Mistrik M, et al. Bratisl Lek Listy. 2016;117(7):388-96. doi: 10.4149/bll_2016_077. Bratisl Lek Listy. 2016. PMID: 27546540
Graft-versus-host disease (GVHD) remains a major problem of allogeneic hematopoietic-stem cell transplantation (HSCT) and an obstacle for successful outcome. ...
Graft-versus-host disease (GVHD) remains a major problem of allogeneic hematopoietic-stem cell transplantation ( …
4,901 results